Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
NCT05407324
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
279
Enrollment
INDUSTRY
Sponsor class
Conditions
Amyotrophic Lateral Sclerosis
Interventions
DRUG:
Dazucorilant 300 mg
DRUG:
Dazucorilant 150 mg
OTHER:
Placebo
DRUG:
Dazucorilant
Sponsor
Corcept Therapeutics